Status: Recruiting
SAD Study in Patients With Parkinson's Disease and Motor Fluctuations
This is a randomized, placebo-controlled, single ascending dose (SAD) study of SER-252 in participants with Parkinson's Disease (PD) and motor fluctuations.
Participants needed: 40
Trial details
Phase: Phase 1Age: 40-80Biological sex: AllType: InterventionalSponsor: Serina TherapeuticsUpdated: Jun 5, 2026Locations: 6
Eligibility criteria
Female or male participants 40-80 years of age, inclusive, at the time of screen... [+12]
Diagnosis of secondary or atypical parkinsonism [+19]